Joint Laboratory of Reproductive Medicine, SCU-CUHK, Key Laboratory of Obstetric, Gynaecologic and Paediatric Diseases and Birth Defects of Ministry of Education, West China Second University Hospital, Med-X Centre for Manufacturing, Sichuan University, Chengdu 610041, People's Republic of China.
Reproduction Medical Centre, West China Second University Hospital, Sichuan University, Chengdu 610041, China.
ACS Sens. 2023 Jun 23;8(6):2186-2196. doi: 10.1021/acssensors.3c00068. Epub 2023 May 24.
To monitor the levels of mitochondrial DNA G-quadruplexes (mtDNA G4s) in spermatozoa and to explore the possibility using mtDNA G4s as a reliable marker in patients with multiple clinical insemination failures, a novel chemical TPE-mTO probe engineered in our previous work was used on both samples from the mice sperm and from patients with fertilization failure. Expression of valosin-containing protein and the zona-free hamster egg assay were used to evaluate mitophagy and human sperm penetration. RNA-sequencing was used to explore expression changes of key genes affected by mtDNA G4s. Results showed that the probe can track mtDNA G4s in spermatozoa easily and quickly with fewer backgrounds. Significantly increased mtDNA G4s were also found in patients with fertilization failure, using the flow-cytometry-based TPE-mTO probe detection method. A sperm-hamster egg penetration experiment showed that abnormal fertilization caused by increased mtDNA G4s can be effectively restored by a mitophagy inducer. This study provides a novel method for monitoring etiological biomarkers in patients with clinical infertility and treatment for patients with abnormal fertilization caused by mtDNA G4 dysfunction.
为了监测精子中线粒体 DNA 四链体(mtDNA G4s)的水平,并探索将 mtDNA G4s 作为多次临床授精失败患者可靠标志物的可能性,我们在前人的工作中设计了一种新型化学 TPE-mTO 探针,用于检测来自小鼠精子和受精失败患者的样本。使用含缬氨酸蛋白和去透明带仓鼠卵穿透实验评估线粒体自噬和人精子穿透。RNA 测序用于探索受 mtDNA G4s 影响的关键基因的表达变化。结果表明,该探针可以轻松快速地追踪精子中的 mtDNA G4s,且背景较少。使用基于流式细胞术的 TPE-mTO 探针检测方法,还发现受精失败患者的 mtDNA G4s 显著增加。一项精子-仓鼠卵穿透实验表明,通过诱导线粒体自噬,可以有效恢复由 mtDNA G4s 增加引起的异常受精。本研究为监测临床不孕患者病因生物标志物和治疗 mtDNA G4 功能障碍引起的异常受精提供了一种新方法。